Caxton Corp.
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Caxton Corp. reported 12 stock positions worth $19.7 million. Its top holding was Xeris Biopharma (XERS) at 58.3% of the portfolio, followed by Rezolute (RZLT, 28.7%) and SS SPDR S&P 500 ETF Trust-US (SPY, 5.2%). Compared with Q1 2024, it opened 1 new position, added to 5 and reduced 1. The biggest buy was Lexeo Therapeutics (LXEO, shares +73%) and the biggest sale Abivax SA-ADR (ABVX, shares −12%).
- Most Recent 13F
- Q2 2026
- Location
- Princeton, NJ
- CIK
- 0001388551
- Portfolio Value
- $19.7M (Q2 2024)
- SEC Filing
- 0000919574-24-004535 ↗ filed Aug 14, 2024
Holdings Value
Holdings 12 stocks · $19.7M
| XERS Xeris Biopharma Holdings Inc. | 58.31% | 5,113,348 | $11.5M | No change |
| RZLT Rezolute Inc. | 28.74% | 1,318,967 | $5.7M | No change |
| SPY SS SPDR S&P 500 ETF Trust-US | 5.15% | 1,869 | $1.0M | Add +0.7% |
| BRK.B Berkshire Hathaway Inc. Class B | 2.11% | 1,025 | $417K | Add +0.6% |
| LXEO Lexeo Therapeutics Inc. | 1.45% | 17,851 | $286K | Add +73.0% |
| MIND MEDICINE MINDMED INC | 1.11% | 30,383 | $219K | Add +4.5% |
| ABVX Abivax SA-ADR | 0.93% | 13,900 | $184K | Reduce -12.1% |
| KYTX Kyverna Therapeutics Inc. | 0.87% | 22,981 | $172K | Add +45.0% |
| MTEMQ Molecular Templates Inc. | 0.80% | 136,866 | $157K | No change |
| CMPX Compass Therapeutics Inc. | 0.22% | 43,465 | $43K | No change |
| CNTX Context Therapeutics Inc. | 0.19% | 18,403 | $37K | New |
| ACET Adicet Bio Inc. | 0.11% | 17,488 | $21K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| ABVX Abivax SA-ADR | Reduce -12.1% | 0.93% | −0.36 |
Portfolio Buys Q1 2024 → Q2 2024
| LXEO Lexeo Therapeutics Inc. | Add +73.0% | 1.45% | +0.53 |
| CNTX Context Therapeutics Inc. | New | 0.19% | +0.19 |
| BRK.B Berkshire Hathaway Inc. Class B | Add +0.6% | 2.11% | −0.33 |
| SPY SS SPDR S&P 500 ETF Trust-US | Add +0.7% | 5.15% | −0.38 |
| MIND MEDICINE MINDMED INC | Add +4.5% | 1.11% | −0.45 |
| KYTX Kyverna Therapeutics Inc. | Add +45.0% | 0.87% | −1.37 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $1.9M | SPCX, BRK.B, GOOGL, VOO, BX |
| Q1 2026 | 7 | $4.0M | GLD, BRK.B, KYTX, LXEO, XFOR |
| Q4 2025 | 11 | $4.3M | GLD, BRK.B, SYRE, MIND MEDICINE MINDMED INC, KYTX |
| Q3 2025 | 12 | $22.9M | RZLT, GLD, BRK.B, MIND MEDICINE MINDMED INC, ELVN |
| Q2 2025 | 11 | $9.9M | RZLT, GLD, BRK.B, ELVN, MIND MEDICINE MINDMED INC |
| Q1 2025 | 12 | $5.1M | RZLT, GLD, BRK.B, MIND MEDICINE MINDMED INC, BCAX |
| Q4 2024 | 15 | $16.6M | XERS, RZLT, SPY, BRK.B, GLD |
| Q3 2024 | 12 | $24.2M | XERS, RZLT, SPY, BRK.B, BCAX |
| Q2 2024 | 12 | $19.7M | XERS, RZLT, SPY, BRK.B, LXEO |
| Q1 2024 | 11 | $17.6M | XERS, RZLT, SPY, BRK.B, KYTX |